Structure and Mechanism of the RISC-loading Complex
RISC加载复合体的结构和机制
基本信息
- 批准号:9133428
- 负责人:
- 金额:$ 38.02万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-09-01 至 2019-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressBenignBiochemicalBiogenesisBiologicalBiological AssayBiological ProcessBiologyBone GrowthBone RegenerationBrainCancer Cell GrowthCancer PatientCardiacCell physiologyClinicalClinical ResearchCodeComplexCrystallographyDICER1 geneDNA Sequence AlterationDataDevelopmentDiagnosisDiseaseElectron MicroscopyEnsureEpithelialEventFertilityGene Expression RegulationGene SilencingGenesGoalsGrowthGuide RNAHandHealthHistocompatibility TestingHomeostasisHumanHuman BiologyHuman GenomeIndividualLiteratureMalignant NeoplasmsMediatingMedicalMethodsMicroRNAsModelingMolecularMolecular AbnormalityMolecular StructureMutationNCOA6 geneNamesOvulationPathway interactionsPatternPhysiological ProcessesProcessProteinsPublishingRNA InterferenceRNA Interference PathwayRNA ProcessingRNA-Induced Silencing ComplexRegulationResearchSeriesStructureSyndromeTherapeuticTissuesWorkX-Ray Crystallographybasecell typeheart functionhuman diseasehuman tissueinnovationinsightmolecular assembly/self assemblymutantparticleprogramstumortumor growthtumorigenesis
项目摘要
DESCRIPTION (provided by applicant): MicroRNAs (miRNAs) are an abundant class of small (~22 nt) regulatory RNAs that control the expression of more than half of all protein-coding genes in humans and are essential components in diverse mammalian physiological processes. Many miRNAs contribute to cellular homeostasis and aberrant miRNA expression is often associated with dysregulated cell growth and cancer. Despite the widespread function of miRNAs in human biology there are fundamental gaps in understanding the molecular mechanisms ensuring fidelity in miRNA biogenesis. Continued existence of these gaps represents a significant medical problem because, until it is filled, understanding of genetic abnormalities in miRNA biogenesis factors that promote tumor growth will remain largely incomprehensible. The long-term goal is to understand the miRNA pathway and related RNA silencing processes to provide detailed insights that can be harnessed for the diagnosis and treatment of human disease. The objective of this application is to dissect the mechanism of the human RISC-loading complex (RLC), which is a large molecular assembly that catalyzes the final steps of miRNA biogenesis and determines which cellular genes are to be down-regulated by the miRNA pathway. The proposed work will explore the hypothesis that genetic mutations in RLC components associated with cancer act by perturbing the mechanism of miRNA biogenesis, leading to aberrant miRNA expression, which in turn drives tumorigenesis. The rational for the proposed research is that detailed understanding of the structure and mechanism of the RLC will provide molecular insights into the biology of diverse human tumors. Guided by strong preliminary data, this objective will be achieved by pursuing two specific aims: 1) Determine structures of the RISC-loading Complex; and 2) Dissect the mechanisms of RISC-loading and guide RNA selection. Under the first aim, X-ray crystallography and electron microscopy will be used to determine molecular structures of the human RLC and its individual components. These efforts will be facilitated by innovative methods for examining small particles by electron microscopy and crystals that are already in hand. Completed results will significantly advance the RNA silencing field because, currently, the only published RLC structure has been shown to be incorrect and the details of how the complex assembles have become muddled and contested in the literature. Under the second aim, discrete RISC-loading steps in wild-type and mutant RLCs will be examined using established biochemical assays. This aim is significant because it will provide mechanistic details into the process of RISC- loading, which is currently only understood at an empirical level, as well as direct and specific insights into how mutations the drive tumorigenesis perturb the mechanisms in miRNA biogenesis. These results will thereby inform efforts to understand and treat diverse forms of cancer. The overall proposal is innovative because it identifies and addresses a specific clinical exigency for biological insight that can be mitigated through proven structural and biochemical approaches.
描述(申请人提供):microRNAs(MiRNAs)是一类丰富的小(~22个核苷酸)调控RNA,控制着人类超过一半的蛋白质编码基因的表达,是各种哺乳动物生理过程中必不可少的组成部分。许多miRNAs有助于细胞内环境的稳定,而miRNA的异常表达往往与细胞生长失调和癌症有关。尽管miRNAs在人类生物学中具有广泛的功能,但在理解miRNA生物发生中确保保真度的分子机制方面仍存在根本差距。这些差距的持续存在代表着一个重大的医学问题,因为在它被填补之前,对促进肿瘤生长的miRNA生物发生因子中的遗传异常的理解在很大程度上仍然是不可理解的。长期目标是了解miRNA途径和相关的RNA沉默过程,以提供可用于人类疾病诊断和治疗的详细见解。本应用的目的是剖析人类RISC负载复合体(RLC)的机制,RLC是一个大的分子组装,催化miRNA生物发生的最后步骤,并确定哪些细胞基因将被miRNA途径下调。拟议的工作将探索这样一种假设,即与癌症相关的RLC组件中的基因突变是通过扰乱miRNA生物发生的机制来发挥作用的,从而导致miRNA表达异常,从而推动肿瘤的发生。提出这项研究的理由是,对RLC结构和机制的详细了解将为各种人类肿瘤的生物学提供分子洞察力。在强大的初步数据的指导下,这一目标将通过追求两个具体目标来实现:1)确定RISC负载复合体的结构;2)剖析RISC负载的机制和指导RNA选择。在第一个目标下,将使用X射线结晶学和电子显微镜来确定人类RLC及其单个成分的分子结构。这些努力将通过电子显微镜检查小颗粒和现有晶体的创新方法来促进。完成的结果将大大推进RNA沉默领域,因为目前唯一发表的RLC结构已被证明是不正确的,复杂组装的细节在文献中变得混乱和有争议。在第二个目标下,野生型和突变型RLCs中的离散RISC加载步骤将使用已建立的生化分析方法进行检查。这一目标具有重要意义,因为它将为RISC加载过程提供机械细节(目前仅在经验水平上了解),以及对驱动肿瘤发生的突变如何扰乱miRNA生物发生机制的直接和具体的见解。因此,这些结果将有助于了解和治疗各种形式的癌症。整个提案是创新的,因为它确定并解决了特定的临床对生物学洞察力的紧迫性,可以通过经过验证的结构和生化方法来缓解这一点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
IAN JOHN MACRAE其他文献
IAN JOHN MACRAE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('IAN JOHN MACRAE', 18)}}的其他基金
Mouse models for decoding microRNA regulation in diverse tissues and cell types
用于解码不同组织和细胞类型中 microRNA 调控的小鼠模型
- 批准号:
10194631 - 财政年份:2021
- 资助金额:
$ 38.02万 - 项目类别:
Mouse models for decoding microRNA regulation in diverse tissues and cell types
用于解码不同组织和细胞类型中 microRNA 调控的小鼠模型
- 批准号:
10043075 - 财政年份:2020
- 资助金额:
$ 38.02万 - 项目类别:
Structural and Mechanistic basis for RNA Silencing
RNA沉默的结构和机制基础
- 批准号:
9979882 - 财政年份:2018
- 资助金额:
$ 38.02万 - 项目类别:
Structural and Mechanistic basis for RNA Silencing
RNA沉默的结构和机制基础
- 批准号:
10448453 - 财政年份:2018
- 资助金额:
$ 38.02万 - 项目类别:
Structural and Mechanistic basis for RNA Silencing
RNA沉默的结构和机制基础
- 批准号:
10213093 - 财政年份:2018
- 资助金额:
$ 38.02万 - 项目类别:
Structural and Mechanistic basis for RNA Silencing
RNA沉默的结构和机制基础
- 批准号:
10623935 - 财政年份:2018
- 资助金额:
$ 38.02万 - 项目类别:
Structure and Mechanism of the RISC-loading Complex
RISC加载复合体的结构和机制
- 批准号:
9314277 - 财政年份:2015
- 资助金额:
$ 38.02万 - 项目类别:
Structural Basis for RNA Silencing by Human Argonaute2
人类 Argonaute2 沉默 RNA 的结构基础
- 批准号:
8708908 - 财政年份:2013
- 资助金额:
$ 38.02万 - 项目类别:
Structural Basis for RNA Silencing by Human Argonaute2
人类 Argonaute2 沉默 RNA 的结构基础
- 批准号:
8852646 - 财政年份:2013
- 资助金额:
$ 38.02万 - 项目类别:
相似海外基金
Genome analysis-based prediction model development for response to stereotactic radiosurgery in benign brain tumors
基于基因组分析的预测模型开发,用于良性脑肿瘤立体定向放射外科治疗的反应
- 批准号:
23K08495 - 财政年份:2023
- 资助金额:
$ 38.02万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Clinical breast cancer risk prediction models for women with a high-risk benign breast diagnosis
高风险良性乳腺诊断女性的临床乳腺癌风险预测模型
- 批准号:
10719777 - 财政年份:2023
- 资助金额:
$ 38.02万 - 项目类别:
Environmentally Benign Precise Transformations of Alkenes by Chiral Chalcogenide Catalysts
手性硫属化物催化剂对环境无害的烯烃精确转化
- 批准号:
22KJ2498 - 财政年份:2023
- 资助金额:
$ 38.02万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Learners to LeAders in benign Urology, benign Nephrology, and non-Cancer Hematology
良性泌尿外科、良性肾脏病学和非癌症血液学领域的学习者和领导者
- 批准号:
10726042 - 财政年份:2023
- 资助金额:
$ 38.02万 - 项目类别:
The role of estrogen receptor alpha in prostatic fibrosis contributing to benign prostatic hyperplasia
雌激素受体α在导致良性前列腺增生的前列腺纤维化中的作用
- 批准号:
10607151 - 财政年份:2023
- 资助金额:
$ 38.02万 - 项目类别:
Development of a medical device to resolve benign esophageal stricture by heating and traction
开发通过加热和牵引解决良性食管狭窄的医疗设备
- 批准号:
23H03765 - 财政年份:2023
- 资助金额:
$ 38.02万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of benign/malignant differentiation method for thyroid follicular tumor using organoids
利用类器官开发甲状腺滤泡性肿瘤良恶性鉴别方法
- 批准号:
23K08075 - 财政年份:2023
- 资助金额:
$ 38.02万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Mechanisms of p53 Engagement and Action at the Benign-to-Malignant Transition in Sporadic Tumorigenesis
p53在散发性肿瘤发生良性向恶性转变中的参与和作用机制
- 批准号:
10720034 - 财政年份:2023
- 资助金额:
$ 38.02万 - 项目类别:
I-Corps: Mitigating Multidrug Resistant Bacterial Infections with Biocompatible and Environmentally Benign Nanoantibiotics
I-Corps:利用生物相容性且对环境无害的纳米抗生素减轻多重耐药细菌感染
- 批准号:
2306943 - 财政年份:2023
- 资助金额:
$ 38.02万 - 项目类别:
Standard Grant
Towards Achieving Zero Emissions through the use of an Environmentally Benign Non-Regenerable Solvent to Capture CO2 from Large Point Source Emitters for Direct Permanent Storage in Geological Formation or Usage in Accelerated Curing of Ready-mix Con
通过使用环境友好的不可再生溶剂从大型点源排放器捕获二氧化碳,直接永久储存在地质构造中或用于预拌混凝土的加速固化,从而实现零排放
- 批准号:
RGPIN-2022-03431 - 财政年份:2022
- 资助金额:
$ 38.02万 - 项目类别:
Discovery Grants Program - Individual